SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $393,300 | -85.4% | 15,000 | -85.6% | 0.00% | -86.7% |
| Q1 2023 | $2,687,256 | -3.3% | 104,400 | -2.2% | 0.02% | +7.1% |
| Q4 2022 | $2,777,868 | +549.0% | 106,800 | +612.0% | 0.01% | +600.0% |
| Q3 2022 | $428,000 | +16.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $369,000 | -56.4% | 15,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $847,000 | -8.9% | 15,000 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $930,000 | -91.2% | 15,000 | -91.0% | 0.00% | -92.3% |
| Q3 2021 | $10,563,000 | +754.6% | 166,500 | +1010.0% | 0.03% | +766.7% |
| Q2 2021 | $1,236,000 | +12.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,104,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |